Rate of discontinuation and reasons for discontinuation of intravesical onabotulinum toxin a in patients with symptomatic overactive bladder (oab)

被引：0
|
作者：
Scrimgeour, Gemma [1 ]
Aleksejeva, Kristina [1 ]
Axell, Richard [1 ]
Yasmin, Habiba [1 ]
Nadeem, Mehwash [1 ]
Unterberg, Stephen [1 ]
Pakzad, Mahreen [1 ]
Hamid, Rizwan [1 ]
Ockrim, Jeremy [1 ]
Greenwell, Tamsin [1 ]
机构：
[1] Univ Coll London Hosp, London, England
来源：
NEUROUROLOGY AND URODYNAMICS | 2020年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
NM49
引用
收藏
页码：S218 / S218
页数：1
相关论文
共 50 条
  • [1] Real world outcomes of intravesical onabotulinum toxin a in patients with symptomatic overactive bladder (oab)
    Scrimgeour, Gemma
    Aleksejeva, Kristina
    Axell, Richard
    Yasmin, Habiba
    Nadeem, Mehwash
    Unterberg, Stephen
    Pakzad, Mahreen
    Hamid, Rizwan
    Ockrim, Jeremy
    Greenwell, Tamsin
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S210 - S211
  • [2] REAL WORLD OUTCOMES OF INTRAVESICAL ONABOTULINUM TOXIN A IN PATIENTS WITH SYMPTOMATIC OVERACTIVE BLADDER
    Scrimgeour, G.
    Aleksejeva, K.
    Axell, R.
    Yasmin, H.
    Nadeem, M.
    Pakzad, M.
    Hamid, R.
    Ockrim, J.
    Greenwell, T.
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S207 - S208
  • [3] FACTORS ASSOCIATED WITH DISCONTINUATION OF ONABOTULINUM TOXIN-A THERAPY FOR OVERACTIVE BLADDER IN A DIVERSE URBAN POPULATION
    Harandi, Arshia Aalami
    Liebeskind, Mariel
    Abraham, Nitya
    JOURNAL OF UROLOGY, 2023, 209 : E414 - E414
  • [4] THE EFFECT OF INTRAVESICAL ONABOTULINUM TOXIN A TREATMENT ON QUALITY OF LIFE IN PATIENTS WITH OVERACTIVE BLADDER
    Arslanoglu, Tugce
    Yasa, Cenk
    Ugurlucan, Funda Gungor
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2023,
  • [5] Higher urge severity score predicts resumption of overactive bladder (OAB) medication following discontinuation of mirabegron treatment in patients with OAB
    Wang, Chung-Cheng
    Jiang, Yung-Hong
    Kuo, Hann-Chorng
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2019, 11 (02) : O180 - O185
  • [6] Regular and Irregular Use and Reasons for Discontinuation of Solifenacin Therapy in Patients with Overactive Bladder Managed by Urologists
    Malkowski, Mateusz
    Almgren-Rachtan, Agnieszka
    Olszanecka-Glinianowicz, Magdalena
    Chudek, Jerzy
    Chlosta, Piotr
    PHARMACEUTICALS, 2024, 17 (01)
  • [7] Deterioration of bladder compliance after botulinum toxin A injection and discontinuation of medication for overactive bladder
    Wada, Naoki
    Ishikawa, Mayumi
    Nagabuchi, Masaya
    Makino, Shogo
    Miyauchi, Kotona
    Abe, Noriyuki
    Kakizaki, Hidehiro
    IJU CASE REPORTS, 2022, 5 (05) : 384 - 388
  • [8] WHICH URODYNAMIC PARAMETERS CAN PREDICT THE OUTCOME OF INTRAVESICAL INJECTIONS OF ONABOTULINUM TOXIN A FOR OVERACTIVE BLADDER?
    Aleksejeva, K.
    Scrimgeour, G.
    Axell, R.
    Yasmin, H.
    Saigal, R.
    Nadeem, M.
    Unterberg, S.
    Pakzad, M.
    Hamid, R.
    Ockrim, J.
    Greenwell, T.
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S428 - S429
  • [9] Which urodynamic parameters can predict outcome of intravesical injections of onabotulinum toxin a for overactive bladder
    Aleksejeva, Kristina
    Scrimgeour, Gemma
    Axell, Richard
    Yasmin, Habiba
    Motan, Daniyal
    Unterberg, Stephen
    Nadeem, Mehwash
    Pakzad, Mahreen
    Hamid, Rizwan
    Ockrim, Jeremy
    Greenwell, Tamsin
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S236 - S237
  • [10] WHICH URODYNAMIC PARAMETERS CAN PREDICT THE OUTCOME OF INTRAVESICAL INJECTIONS OF ONABOTULINUM TOXIN A FOR OVERACTIVE BLADDER?
    Aleksejeva, Kristina
    Scrimgeour, Gemma
    Axell, Richard
    Yasmin, Habiba
    Motan, Daniyal
    Unterberg, Stephen
    Pakzad, Mahreen
    Hamid, Rizwan
    Ockrim, Jeremy
    Greenwell, Tamsin
    JOURNAL OF UROLOGY, 2020, 203 : E477 - E478
12345